Glutarylation of XRCC4 Enhances Breast Cancer Response to PARP Inhibitors
A new study in Cellular Oncology reveals that glutarylation of the XRCC4 protein promotes its degradation, thereby enhancing the sensitivity ...
A new study in Cellular Oncology reveals that glutarylation of the XRCC4 protein promotes its degradation, thereby enhancing the sensitivity ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.